Review Article
Androgen Deprivation Therapy Toxicity and Management for Men Receiving Radiation Therapy
Table 1
Suggested management for patients receiving androgen deprivation therapy.
| At time of ADT1 initiation | |
| Patient education on spectrum of expected side effects | | Education on initiation of exercise program | | Patient resources at http://go4life.nia.nih.gov/ | | Education on diet and weight management | | Obtain baseline weight | | Patient resources at http://www.choosemyplate.gov/ | | Inform primary care physician of modality and duration of ADT | | Baseline lipid panel | | Blood pressure measurement | | Insulin resistance screening | | Smoking cessation | | Baseline DEXA2 scan | | Assess fracture risk at http://www.shef.ac.uk/FRAX/ | |
| Year 1 | |
| Ensure continued followup with primary care physician | | Blood pressure management | | Lipid monitoring | | Weight management | | Diabetes screening | | Ongoing screening for depression, sexual side effects, and hot flushes | |
| Year 2-3 | |
| Ensure continued followup with primary care physician | | Blood pressure management | | Lipid monitoring | | Weight management | | Diabetes screening | | Ongoing screening for depression, sexual side effects, and hot flushes | | DEXA scan | | Reassess fracture risk at http://www.shef.ac.uk/FRAX/ | |
|
|
Androgen deprivation therapy, 2dual-energy X-ray absorptiometry.
|